[1]
R. Mishra and S. Dhole, “DIPEPTIDYL PEPTIDASE-4 INHIBITORS: POTENTIAL FOR TREATMENT OF METABOLIC SYNDROME AND DEVELOPED FORMULATION APPROACHES”, Asian J Pharm Clin Res, vol. 10, no. 11, pp. 20–26, Nov. 2017.